MISSION
The Cerebrovascular and Neurointerventional Research Laboratory is dedicated to pioneering advancements in the field of Neurointerventional surgery. Our research team is deeply committed to enhancing clinical practices and outcomes for patients suffering from a spectrum of cerebrovascular disorders, including stroke, aneurysmal subarachnoid hemorrhage, unruptured aneurysms, carotid artery disease, cerebral venous sinus thrombosis (CVST), and other related conditions. Through our focused clinical research, we strive to forge new frontiers in endovascular treatments and patient care.

Santiago Ortega-Gutierrez
Associate Professor of Neurology, Neurosurgery and Radiology
President-Elect, Society of Vascular and Interventional Neurology
Vice Chair, Mechanical Thrombectomy 2020+ Initiative
Director of Neurointerventional Surgery in Neurology
Director, Neuroendovascular Surgical Neuroradiology Fellowship
Department of Neurology, Neurosurgery and Radiology

FDA Clears Methinks AI—Paving the Way for Simpler Stroke Imaging and Wider EVT Access
The US FDA has granted 510(k) clearance to Methinks AI’s NCCT Stroke software, a milestone for stroke care and an exciting development in the push for imaging simplification as a gateway to mechanical thrombectomy (EVT).
Using only non-contrast CT (NCCT)—the most accessible imaging modality worldwide Methinks AI’s software can now detect:
- Large vessel occlusions (LVOs)
- Distal occlusions (including M2 segment of the MCA)
- Intracranial hemorrhages (ICHs)
This capability is especially important for hospitals without access to contrast CT or advanced perfusion imaging. By enabling accurate stroke triage using plain CT, Methinks NCCT Stroke offers a scalable tool to support earlier decision-making, faster transfer, and expanded EVT eligibility, even in rural, low-resource, or under-equipped facilities.
“Methinks NCCT can unlock lifesaving decisions at any hospital,” said CEO Pau Rodríguez.
“No patient should be left behind due to imaging limitations.”
In FDA validation studies, the software demonstrated a significant reduction in false negatives compared to other NCCT tools and is uniquely integrated into Microsoft Teams, supporting real-time stroke team collaboration and seamless PACS integration.
This clearance builds on Methinks’ recent partnership with Medtronic, aimed at extending stroke triage solutions across Central and Eastern Europe, Africa, Turkey, and the Middle East.
As the field of stroke care continues to evolve, this announcement strengthens the case for plain CT + AI as a viable front door to EVT, supporting the mission of making advanced stroke care truly global.

MAP-STROKE Featured by Medscape – Smarter Routing, Better Outcomes in Stroke Care
We’re excited to share that our MAP-STROKE study was highlighted by Medscape Medical News for its potential to reshape prehospital stroke routing.
Using simulations of over 115 million stroke scenarios, the study showed that a data-driven algorithm could substantially improve functional outcomes by directing patients especially those with suspected large vessel occlusions (LVO) to the most appropriate stroke centers more quickly.
Highlights:
- Potential for 12,000 more patients/year in the U.S. to reach a good neurological recovery
- Up to 180 minutes saved in time-to-EVT for rural LVO stroke patients
- Based on NIH-funded research; next step: real-world validation
“The algorithm doesn’t replace clinical judgment, algorithm enhances it by helping paramedics make smarter routing decisions in the field,” said Dr. Santiago Ortega-Gutierrez.
Contact Us
We are always looking for people/teams to collaborate with! If interested in joining the lab please email our PI with a letter of interest including your CV, research interests, and future goals.
Follow our X/twitter account!
Follow our LinkedIn account!